The MarketWatch News Department was not involved in the creation of this content. New data show zero device-related complications or atrial fibrillation, no recurrent stroke or TIA, with a cohort 40% ...
Sahajanand Medical Technologies (SMT) is using its Cocoon Occluder devices to treat congenital heart defects like atrial septal defect and patent foramen ovale. These minimally invasive devices ...
While other device-based closures have demonstrated notable rates of atrial fibrillation (5.7–6.6%) and device-related adverse events, the NobleStitch™ system's fully suture-mediated approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback